Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Interest Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Interest Expenses for 16 consecutive years, with $904000.0 as the latest value for Q3 2025.

  • Quarterly Interest Expenses fell 24.6% to $904000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Sep 2025, up 6.32% year-over-year, with the annual reading at $4.2 million for FY2024, 41.59% up from the prior year.
  • Interest Expenses for Q3 2025 was $904000.0 at Xtant Medical Holdings, down from $1.0 million in the prior quarter.
  • The five-year high for Interest Expenses was $1.2 million in Q3 2024, with the low at $1000.0 in Q1 2021.
  • Average Interest Expenses over 5 years is $670421.1, with a median of $760000.0 recorded in 2023.
  • The sharpest move saw Interest Expenses crashed 99.91% in 2021, then surged 35800.0% in 2022.
  • Over 5 years, Interest Expenses stood at $466000.0 in 2021, then grew by 6.22% to $495000.0 in 2022, then surged by 65.25% to $818000.0 in 2023, then soared by 38.63% to $1.1 million in 2024, then decreased by 20.28% to $904000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $904000.0, $1.0 million, and $1.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.